Overview

The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment

Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
0
Participant gender:
All
Summary
This study will evaluate the individual and interactive effects of oral cannabis and alcohol on subjective and behavioral measures of impairment.
Phase:
Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
National Institute on Drug Abuse (NIDA)
Criteria
Inclusion Criteria:

1. Have provided written informed consent

2. Be between the ages of 21 and 50

3. Be in good general health based on a physical examination, medical history, vital
signs, and screening urine and blood tests

4. Not be pregnant or nursing (if female). All females must have a negative serum
pregnancy test at the screening visit and a negative urine pregnancy test at each
study visit.

5. Have a body mass index (BMI) in the range of 19 to 36 kg/m2

6. Blood pressure at Screening Visit does not exceed a systolic blood pressure (SBP) of
150 mmHg or a diastolic blood pressure (DBP) of 90 mmHg

7. Have not donated blood in the prior 30 days.

8. For women, consume ≥ 7 alcoholic drinks/week and for men, consume, ≥ 14 alcoholic
drinks/week

9. Report at least 1 day of binge drinking in the past 90 days (greater than 4 or 5
drinks on a single occasion for women and men, respectively)

10. Report ≥ 5 uses of cannabis in the past year

11. Provide negative urine test for illicit drug use (excluding THC) and negative breath
alcohol test (0% BAC) at screening and before study sessions

12. Report at least 1 instance of simultaneous alcohol and use in the past year.

Exclusion Criteria:

1. Psychoactive drug use (aside from cannabis, nicotine, alcohol, or caffeine) in past
month

2. Current use of over-the-counter (OTC) drugs, supplements/vitamins, or prescription
medications that, in the opinion of the investigator or medical staff, will impact the
participant's safety

3. History of or current evidence of significant medical condition

4. Evidence of current psychiatric condition [(MINI for Diagnostic and Statistical Manual
(DSM)-V)]

5. Meet criteria for severe alcohol use disorder (MINI for DSM-V)

6. Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar) score > 9

7. Been in treatment previously for alcohol or cannabis use disorder

8. Use of cannabis, on average, more than 2 times/week over past 3 months

9. Liver function tests more than 2x normal range

10. Enrollment in another clinical trial or receiving of any drug as part of research
within past 30 days

11. Shipley vocabulary score <18 (corresponds to 5th grade reading level).